The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan and a calcium channel blocker (amlodipine) in type 2 diabetic hypertensive patients: The OLCA study

Effect of Fixed‐Dose ACE‐Inhibitor/Calcium Channel Blocker Combination Therapy vs. ACE‐Inhibitor Monotherapy on Arterial Compliance in Hypertensive Patients With Type 2 Diabetes

Preventive Cardiology ◽

10.1111/j.1520-037x.2005.3535.x ◽

2005 ◽

Vol 8 (2) ◽

pp. 87-92 ◽

Cited By ~ 13

Author(s):

Nathaniel Winer ◽

Amy Folker ◽

Julie A. Murphy ◽

Elena Hung ◽

Mara Bard ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Ace Inhibitor ◽

Channel Blocker ◽

Arterial Compliance ◽

Fixed Dose ◽

Hypertensive Patients

Calcium Channel Blocker Enhances Beneficial Effects of an Angiotensin II AT1 Receptor Blocker against Cerebrovascular-Renal Injury in type 2 Diabetic Mice

PLoS ONE ◽

10.1371/journal.pone.0082082 ◽

2013 ◽

Vol 8 (12) ◽

pp. e82082 ◽

Cited By ~ 4

Author(s):

Kazi Rafiq ◽

Shamshad J. Sherajee ◽

Hirofumi Hitomi ◽

Daisuke Nakano ◽

Hiroyuki Kobori ◽

...

Keyword(s):

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Renal Injury ◽

Channel Blocker ◽

Diabetic Mice ◽

At1 Receptor Blocker ◽

Beneficial Effects ◽

Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria

Hypertension Research ◽

10.1038/hr.2012.45 ◽

2012 ◽

Vol 35 (8) ◽

pp. 874-881 ◽

Cited By ~ 12

Author(s):

Masanori Abe ◽

Noriaki Maruyama ◽

Hiroko Suzuki ◽

Yuki Fujii ◽

Midori Ito ◽

...

Keyword(s):

Calcium Channel ◽

Calcium Channel Blocker ◽

Angiotensin Receptor Blocker ◽

Channel Blocker ◽

Receptor Blocker ◽

Diabetic Patients ◽

Angiotensin Receptor ◽

Nifedipine, a Calcium-Channel Blocker, Attenuated Glucose Intolerance and White Adipose Tissue Dysfunction in Type 2 Diabetic KK-Ay Mice

American Journal of Hypertension ◽

10.1038/ajh.2010.198 ◽

2011 ◽

Vol 24 (2) ◽

pp. 169-174 ◽

Cited By ~ 10

Author(s):

M. Iwai ◽

H. Kanno ◽

S. Inaba ◽

I. Senba ◽

H. Sone ◽

...

Keyword(s):

Adipose Tissue ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Glucose Intolerance ◽

White Adipose Tissue ◽

Channel Blocker ◽

Adipose Tissue Dysfunction ◽

Type 2 Diabetic ◽

Ay Mice

Effects of Olmesartan, an Angiotensin II Receptor Blocker, and Amlodipine, a Calcium Channel Blocker, on Cardio-Ankle Vascular Index (CAVI) in Type 2 Diabetic Patients with Hypertension

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.erratum2009_912 ◽

2009 ◽

Vol 16 (6) ◽

pp. 912-912

Author(s):

Yoh Miyashita ◽

Atsuhito Saiki ◽

Kei Endo ◽

Noriko Ban ◽

Takashi Yamaguchi ◽

...

Keyword(s):

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Diabetic Patients ◽

Angiotensin Ii Receptor ◽

Effects of Olmesartan, an Angiotensin II Receptor Blocker, and Amlodipine, a Calcium Channel Blocker, on Cardio-Ankle Vascular Index (CAVI) in Type 2 Diabetic Patients with Hypertension

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.497 ◽

2009 ◽

Vol 16 (5) ◽

pp. 621-626 ◽

Cited By ~ 40

Author(s):

Yoh Miyashita ◽

Atsuhito Saiki ◽

Kei Endo ◽

Noriko Ban ◽

Takashi Yamaguchi ◽

...

Keyword(s):

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Diabetic Patients ◽

Angiotensin Ii Receptor ◽

Safety and efficacy of an ACE inhibitor/calcium channel blocker combination versus an ACE inhibitor alone in hypertensive patients with type 2 diabetes

American Journal of Hypertension ◽

10.1016/s0895-7061(02)02744-9 ◽

2002 ◽

Vol 15 (4) ◽

pp. A173 ◽

Cited By ~ 1

Author(s):

G BAKRIS

Keyword(s):

Type 2 Diabetes ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Ace Inhibitor ◽

Channel Blocker ◽

Hypertensive Patients ◽

Safety And Efficacy

Protective Effects of Efonidipine, a T- and L-Type Calcium Channel Blocker, on Renal Function and Arterial Stiffness in Type 2 Diabetic Patients with Hypertension and Nephropathy

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.1628 ◽

2009 ◽

Vol 16 (5) ◽

pp. 568-575 ◽

Cited By ~ 47

Author(s):

Hidehisa Sasaki ◽

Atsuhito Saiki ◽

Kei Endo ◽

Noriko Ban ◽

Takashi Yamaguchi ◽

...

Keyword(s):

Renal Function ◽

Arterial Stiffness ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Diabetic Patients ◽

Protective Effects ◽

Combination Therapy of Calcium Channel Blocker and Angiotensin II Receptor Blocker Reduces Augmentation Index in Hypertensive Patients

The American Journal of the Medical Sciences ◽

10.1097/maj.0b013e3181d658c4 ◽

2010 ◽

Vol 339 (5) ◽

pp. 433-439 ◽

Cited By ~ 16

Author(s):

Masayuki Doi ◽

Toru Miyoshi ◽

Satoshi Hirohata ◽

Shigeshi Kamikawa ◽

Hiroko Ogawa ◽

...

Keyword(s):

Angiotensin Ii ◽

Combination Therapy ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Augmentation Index ◽

Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Hypertensive Patients

Protective Effects of an Angiotensin II Receptor Blocker and a Long-Acting Calcium Channel Blocker against Cardiovascular Organ Injuries in Hypertensive Patients

Hypertension Research ◽

10.1291/hypres.28.351 ◽

2005 ◽

Vol 28 (4) ◽

pp. 351-359 ◽

Cited By ~ 20

Author(s):

Toshihiko ISHIMITSU ◽

Tsutomu KOBAYASHI ◽

Takeaki HONDA ◽

Masaki TAKAHASHI ◽

Junichi MINAMI ◽

...

Keyword(s):

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Receptor Blocker ◽

Protective Effects ◽

Angiotensin Ii Receptor ◽

Hypertensive Patients ◽

Long Acting